Valentina Salvestrini
Valentina Salvestrini
1Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy
1,*,†,
Marilena Ciciarello
Marilena Ciciarello
1Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy
1,†,
Valentina Pensato
Valentina Pensato
1Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy
1,
Giorgia Simonetti
Giorgia Simonetti
2Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy
2,
Maria Antonella Laginestra
Maria Antonella Laginestra
1Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy
3Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
1,3,
Samantha Bruno
Samantha Bruno
1Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy
1,
Martina Pazzaglia
Martina Pazzaglia
1Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy
1,
Elena De Marchi
Elena De Marchi
4Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Ferrara, Italy
4,
Dorian Forte
Dorian Forte
1Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy
1,
Stefania Orecchioni
Stefania Orecchioni
5Laboratory of Hematology-Oncology, IRCCS European Institute of Oncology, Milan, Italy
5,
Giovanni Martinelli
Giovanni Martinelli
2Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy
2,
Francesco Bertolini
Francesco Bertolini
5Laboratory of Hematology-Oncology, IRCCS European Institute of Oncology, Milan, Italy
5,
Simon Méndez-Ferrer
Simon Méndez-Ferrer
5Laboratory of Hematology-Oncology, IRCCS European Institute of Oncology, Milan, Italy
6Department of Haematology, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute University of Cambridge, Cambridge, United Kingdom
7Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
5,6,7,
Elena Adinolfi
Elena Adinolfi
4Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Ferrara, Italy
4,
Francesco Di Virgilio
Francesco Di Virgilio
4Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Ferrara, Italy
4,
Michele Cavo
Michele Cavo
1Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy
1,
Antonio Curti
Antonio Curti
8Department of Oncology and Hematology, Institute of Hematology “L. and A. Seràgnoli”, University-Hospital S.Orsola-Malpighi, Bologna, Italy
8
1Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy
2Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy
3Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
4Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Ferrara, Italy
5Laboratory of Hematology-Oncology, IRCCS European Institute of Oncology, Milan, Italy
6Department of Haematology, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute University of Cambridge, Cambridge, United Kingdom
7Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
8Department of Oncology and Hematology, Institute of Hematology “L. and A. Seràgnoli”, University-Hospital S.Orsola-Malpighi, Bologna, Italy
Edited and reviewed by: J. Luis Espinoza, Kanazawa University, Japan
✉*Correspondence: Valentina Salvestrini, valentin.salvestrin2@unibo.it
This article was submitted to Hematologic Malignancies, a section of the journal Frontiers in Oncology
†These authors have contributed equally to this work
Received 2021 Feb 16; Accepted 2021 Mar 18; Collection date 2021.
Keywords: acute myeloid leukemia, bitter taste receptors, denatonium benzoate, bone marrow microenvironment, bitter compounds
Copyright © 2021 Salvestrini, Ciciarello, Pensato, Simonetti, Laginestra, Bruno, Pazzaglia, De Marchi, Forte, Orecchioni, Martinelli, Bertolini, Méndez-Ferrer, Adinolfi, Di Virgilio, Cavo and Curti
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.